Comments on: FDA grants priority review designation for Boehringer’s idiopathic pulmonary fibrosis therapy

Comments on: FDA grants priority review designation for Boehringer’s idiopathic pulmonary fibrosis therapy /news/newsfda-grants-priority-review-designation-boehringers-idiopathic-pulmonary-fibrosis-therapy-4309364/ The leading site for news and procurement in the pharmaceutical industry Wed, 02 Jul 2014 17:30:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2